What does PPPharmacy do?

PPPharmacy is a pharmacy in Gent. Private Limited, started on 26 March 2021, 1 establishment.

What is the address of PPPharmacy?

The registered office of PPPharmacy is located at De Pintelaan 164, 9000 Gent.

Is PPPharmacy still active?

Yes. According to the CBE (31 October 2026) PPPharmacy is active, legal situation “Normale toestand”, started on 26 March 2021.

Is PPPharmacy registered on Peppol?

Yes, PPPharmacy is registered on the Peppol network with ID 0208:0765736905.

What is the enterprise number of PPPharmacy?

The enterprise number of PPPharmacy is BE0765736905.

When was PPPharmacy founded?

PPPharmacy was founded on 26 March 2021.

Is PPPharmacy a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 March 2021; 4 annual accounts filed, latest fiscal year 2025.

How much profit did PPPharmacy make in 2025?

PPPharmacy posted a profit after taxes of € 49,925 in financial year 2025.

What is the revenue of PPPharmacy?

As a small company, PPPharmacy is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 70,831.

PPPharmacy (Private Limited) - Gent - BE0765736905

Dossier PPPharmacy, printed on 1 November 2026 from databakkes.be/en/0765736905/pppharmacy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PPPharmacy from Gent, company number BE0765736905, closed financial year 2025 with a result of € 49,925 after tax. For that financial year PPPharmacy recorded a gross margin of € 70,831 and equity of € 84,763. Compared with financial year 2024, the result moved from € 76,898 to € 49,925. The company is profitable. The buffer shrank hard: equity is 62 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 24, 2026.

What it is worth Shrank hard

€ 84,763

▼ 62% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 49,925

▼ 35% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 65,933

▼ 70% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 189,276 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 3,919

▼ 61% vs 2024

Of which on lease € 3,919.

Debts at end 2025

Bank debt

€ 3,665

▼ 57% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 2,599

▲ 27% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,638

▲ 65% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 112,361 Gross margin 2022: € 112,361 First fiscal year in the series	€ 84,467 Gross margin 2023: € 84,467 ▼ 25% vs 2022 (€ 112,361) Unfavourable step	€ 104,314 Gross margin 2024: € 104,314 ▲ 23% vs 2023 (€ 84,467) Favourable step	€ 70,831 Gross margin 2025: € 70,831 ▼ 32% vs 2024 (€ 104,314) Unfavourable step	▼ 32%
Profit after taxes	€ 81,243 Profit after taxes 2022: € 81,243 First fiscal year in the series	€ 60,973 Profit after taxes 2023: € 60,973 ▼ 25% vs 2022 (€ 81,243) Unfavourable step	€ 76,898 Profit after taxes 2024: € 76,898 ▲ 26% vs 2023 (€ 60,973) Favourable step	€ 49,925 Profit after taxes 2025: € 49,925 ▼ 35% vs 2024 (€ 76,898) Unfavourable step	▼ 35%
Equity	€ 86,243 Equity 2022: € 86,243 First fiscal year in the series	€ 147,216 Equity 2023: € 147,216 ▲ 71% vs 2022 (€ 86,243) Favourable step	€ 224,114 Equity 2024: € 224,114 ▲ 52% vs 2023 (€ 147,216) Favourable step	€ 84,763 Equity 2025: € 84,763 ▼ 62% vs 2024 (€ 224,114) Unfavourable step	▼ 62%
Total debts	€ 38,999 Total debts 2022: € 38,999 First fiscal year in the series	€ 27,429 Total debts 2023: € 27,429 ▼ 30% vs 2022 (€ 38,999) Favourable step	€ 25,118 Total debts 2024: € 25,118 ▼ 8% vs 2023 (€ 27,429) Favourable step	€ 22,005 Total debts 2025: € 22,005 ▼ 12% vs 2024 (€ 25,118) Favourable step	▼ 12%
Cash	€ 81,031 Cash 2022: € 81,031 First fiscal year in the series	€ 146,934 Cash 2023: € 146,934 ▲ 81% vs 2022 (€ 81,031) Favourable step	€ 219,034 Cash 2024: € 219,034 ▲ 49% vs 2023 (€ 146,934) Favourable step	€ 65,933 Cash 2025: € 65,933 ▼ 70% vs 2024 (€ 219,034) Unfavourable step	▼ 70%
Retained profit	€ 81,243 Retained profit 2022: € 81,243 First fiscal year in the series	€ 142,216 Retained profit 2023: € 142,216 ▲ 75% vs 2022 (€ 81,243) Favourable step	€ 219,114 Retained profit 2024: € 219,114 ▲ 54% vs 2023 (€ 142,216) Favourable step	€ 79,763 Retained profit 2025: € 79,763 ▼ 64% vs 2024 (€ 219,114) Unfavourable step	▼ 64%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 189,276 Dividend 2025: € 189,276 Unchanged (€ 0) Unchanged
Bank debt	€ 17,996 Bank debt 2022: € 17,996 First fiscal year in the series	€ 13,277 Bank debt 2023: € 13,277 ▼ 26% vs 2022 (€ 17,996) Favourable step	€ 8,501 Bank debt 2024: € 8,501 ▼ 36% vs 2023 (€ 13,277) Favourable step	€ 3,665 Bank debt 2025: € 3,665 ▼ 57% vs 2024 (€ 8,501) Favourable step	▼ 57%
Balance sheet total	€ 125,242 Balance sheet total 2022: € 125,242 First fiscal year in the series	€ 174,644 Balance sheet total 2023: € 174,644 ▲ 39% vs 2022 (€ 125,242) Unchanged	€ 249,231 Balance sheet total 2024: € 249,231 ▲ 43% vs 2023 (€ 174,644) Unchanged	€ 106,768 Balance sheet total 2025: € 106,768 ▼ 57% vs 2024 (€ 249,231) Unchanged	▼ 57%

Key figures of PPPharmacy, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to PPPharmacy?

What happened at PPPharmacy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 24, 2026 New annual accounts for financial year 2025: profit of € 49,925 (▼ 35% vs 2024). Source: NBB ↗
Mar 26, 2021 New establishment in Gent. KBO
Mar 26, 2021 Start of the company according to the CBE. KBO

In short

From € 81,243 profit in 2022 to € 49,925 profit in 2025.

Paid € 70,237 in corporate taxes since 2022.

Best year ever: 2022, with € 81,243 profit.

Paid out € 189,276 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

De Pintelaan 164

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0765.736.905
VAT number: BE 0765.736.905
Registered office: De Pintelaan 164, 9000 Gent
Names & denominations: PPPharmacy
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 March 2021
Peppol: Active · Active since 31 Oct 2023
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PPPharmacy

Financials

What happened to PPPharmacy?

Establishments

Establishment units

Details

Frequently asked questions